KRTAP1-5
gene geneOn this page
Also known as KAP1.5
Summary
KRTAP1-5 (keratin associated protein 1-5, HGNC:16777) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 1-5 (Q9BYS1). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
This protein is a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This protein is a member of the high sulfur KAP family and the gene is localized to a cluster of KAPs at 17q12-q21.
Source: NCBI Gene 83895 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_031957
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16777 |
| Approved symbol | KRTAP1-5 |
| Name | keratin associated protein 1-5 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP1.5 |
| Ensembl gene | ENSG00000221852 |
| Ensembl biotype | protein_coding |
| OMIM | 608822 |
| Entrez | 83895 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000361883
RefSeq mRNA: 1 — MANE Select: NM_031957
NM_031957
CCDS: CCDS42321
Canonical transcript exons
ENST00000361883 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001475002 | 41026026 | 41027208 |
Expression profiles
Bgee: expression breadth broad, 57 present calls, max score 90.18.
FANTOM5 (CAGE): breadth broad, TPM avg 4.7064 / max 636.3669, expressed in 344 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165865 | 4.7064 | 344 |
Top tissues by expression
110 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.18 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.02 | gold quality |
| endocervix | UBERON:0000458 | 53.15 | gold quality |
| ectocervix | UBERON:0012249 | 52.48 | gold quality |
| uterine cervix | UBERON:0000002 | 51.33 | gold quality |
| skin of abdomen | UBERON:0001416 | 50.27 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.57 | gold quality |
| zone of skin | UBERON:0000014 | 49.05 | gold quality |
| skin of leg | UBERON:0001511 | 48.55 | gold quality |
| vagina | UBERON:0000996 | 45.55 | gold quality |
| right lung | UBERON:0002167 | 41.09 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 38.54 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 35.79 | gold quality |
| mucosa of stomach | UBERON:0001199 | 35.62 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| placenta | UBERON:0001987 | 35.45 | silver quality |
| tibial artery | UBERON:0007610 | 34.58 | gold quality |
| popliteal artery | UBERON:0002250 | 34.53 | gold quality |
| prostate gland | UBERON:0002367 | 34.35 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 33.62 | gold quality |
| adipose tissue | UBERON:0001013 | 33.49 | gold quality |
| muscle tissue | UBERON:0002385 | 33.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| myometrium | UBERON:0001296 | 33.19 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 32.99 | silver quality |
| gall bladder | UBERON:0002110 | 32.26 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.50 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
58 targeting KRTAP1-5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-6134 | 99.63 | 65.68 | 1537 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-3614-5P | 99.30 | 65.25 | 837 |
| HSA-MIR-410-3P | 99.27 | 69.98 | 2457 |
Literature-anchored findings (GeneRIF, showing 1)
- no polymorphic alleles were found for the hKAP1.4 and hKAP1.5 genes in Japanese and Caucasian individuals (PMID:12228244)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krtap1-5 | ENSMUSG00000047253 |
| rattus_norvegicus | Krtap1-5 | ENSRNOG00000084854 |
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 1-5 — Q9BYS1 (reviewed: Q9BYS1)
Alternative names: High sulfur keratin-associated protein 1.5, Keratin-associated protein 1.5
All UniProt accessions (1): Q9BYS1
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Expressed in the middle/upper portions of the hair cortex, in the region termed the keratogenous zone.
Similarity. Belongs to the KRTAP type 1 family.
RefSeq proteins (1): NP_114163* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
Pfam: PF01500
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYS1-F1 | 39.52 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 26 (showing top):
RIGGI_EWING_SARCOMA_PROGENITOR_DN, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, YOSHIMURA_MAPK8_TARGETS_UP, CHICAS_RB1_TARGETS_CONFLUENT, MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN, GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP, MIR4261, MIR5692B_MIR5692C, MIR4251
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
302 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP1-5 | KRTAP3-2 | Q9BYR7 | 538 |
| KRTAP1-5 | A0A3B3IRQ3 | A0A3B3IRQ3 | 506 |
| KRTAP1-5 | KRTAP3-1 | Q9BYR8 | 484 |
| KRTAP1-5 | KRTAP9-4 | Q9BYQ2 | 469 |
| KRTAP1-5 | KRTAP2-3 | P0C7H8 | 446 |
| KRTAP1-5 | SLC35G6 | P0C7Q6 | 419 |
| KRTAP1-5 | KRTAP17-1 | Q9BYP8 | 409 |
| KRTAP1-5 | ZNF808 | Q8N4W9 | 400 |
| KRTAP1-5 | KRTAP19-1 | Q8IUB9 | 400 |
| KRTAP1-5 | KRT34 | O76011 | 397 |
| KRTAP1-5 | KRTAP5-7 | Q6L8G8 | 396 |
| KRTAP1-5 | LHFPL7 | Q6ICI0 | 384 |
| KRTAP1-5 | KRTAP5-11 | Q6L8G4 | 379 |
| KRTAP1-5 | KRT27 | Q7Z3Y8 | 377 |
| KRTAP1-5 | KRTAP5-5 | Q701N2 | 374 |
IntAct
130 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP1-5 | LCE1D | psi-mi:“MI:0915”(physical association) | 0.700 |
| KRTAP1-5 | OTX1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| LCE1D | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.700 |
| OTX1 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.700 |
| LCE3A | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE1B | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP1-5 | LCE1B | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP1-5 | LCE3A | psi-mi:“MI:0915”(physical association) | 0.600 |
| FADS6 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP4-11 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CREB5 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUFIP2 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXB9 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KPRP | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP9-2 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE2D | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP4-4 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-5 | SHFL | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADAMTSL4 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1E | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GUCD1 | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | KRTAP1-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (49): LCE1D (Two-hybrid), OTX1 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid), KRTAP1-5 (Two-hybrid)
ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YEY9, A0A286YF01, A0A286YF46, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, O14633, P02438, P04459, P05687, P05688, P08131, P08175, P0DSO2, P20730, Q01642, Q01643, Q01644, Q01645, Q07627, Q3LI58, Q3LI59, Q3V2C1, Q5T750, Q5T752, Q5T754, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q8IUC1, Q8IUG1, Q9BQ66, Q9BYP8, Q9BYQ5, Q9BYQ6
Diamond homologs: P02438, P02439, P02440, P08131, P0C5Y4, Q07627, Q3V2C1, Q8IUG1, Q9BYS1
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 39 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 16 | 30.7× | 2e-19 |
| Formation of the cornified envelope | 9 | 27.3× | 4e-10 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 9 | 63.8× | 3e-12 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
319 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41026470:T:TC | acceptor_gain | 0.8300 |
| 17:41026468:CAT:C | acceptor_gain | 0.8000 |
| 17:41026273:T:TC | acceptor_gain | 0.7900 |
| 17:41026396:AT:A | donor_gain | 0.7700 |
| 17:41026470:T:C | acceptor_gain | 0.7700 |
| 17:41026273:T:C | acceptor_gain | 0.7500 |
| 17:41026396:ATC:A | donor_gain | 0.7400 |
| 17:41026398:C:A | donor_gain | 0.7400 |
| 17:41026370:T:TA | donor_gain | 0.7300 |
| 17:41026397:T:TA | donor_gain | 0.7100 |
| 17:41026802:C:CT | donor_gain | 0.7000 |
| 17:41026261:T:TC | acceptor_gain | 0.6900 |
| 17:41026368:AAT:A | donor_gain | 0.6900 |
| 17:41026803:C:CT | donor_gain | 0.6900 |
| 17:41026286:A:C | acceptor_gain | 0.6800 |
| 17:41026472:G:C | acceptor_gain | 0.6700 |
| 17:41026271:T:TC | acceptor_gain | 0.6500 |
| 17:41026272:T:C | acceptor_gain | 0.6500 |
| 17:41026472:G:GC | acceptor_gain | 0.6500 |
| 17:41026270:A:AC | acceptor_gain | 0.6400 |
| 17:41026282:CAAGA:C | acceptor_gain | 0.6300 |
| 17:41026394:ATAT:A | donor_gain | 0.6200 |
| 17:41026397:T:C | donor_gain | 0.5800 |
| 17:41026264:C:CT | acceptor_gain | 0.5700 |
| 17:41026954:T:TA | donor_gain | 0.5700 |
| 17:41026270:A:C | acceptor_gain | 0.5600 |
| 17:41026271:T:C | acceptor_gain | 0.5600 |
| 17:41027062:T:TA | donor_gain | 0.5500 |
| 17:41026261:T:C | acceptor_gain | 0.5400 |
| 17:41026265:A:T | acceptor_gain | 0.5400 |
AlphaMissense
1160 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41026802:C:A | W118C | 0.853 |
| 17:41026802:C:G | W118C | 0.853 |
| 17:41026804:A:G | W118R | 0.845 |
| 17:41026804:A:T | W118R | 0.845 |
| 17:41026679:A:C | C159W | 0.813 |
| 17:41026729:A:G | C143R | 0.812 |
| 17:41026680:C:G | C159S | 0.810 |
| 17:41026681:A:T | C159S | 0.810 |
| 17:41026727:G:C | C143W | 0.802 |
| 17:41026694:G:C | C154W | 0.795 |
| 17:41026724:G:C | C144W | 0.789 |
| 17:41026726:A:G | C144R | 0.789 |
| 17:41026725:C:G | C144S | 0.786 |
| 17:41026726:A:T | C144S | 0.786 |
| 17:41026696:A:G | C154R | 0.781 |
| 17:41026681:A:G | C159R | 0.770 |
| 17:41026684:A:C | Y158D | 0.768 |
| 17:41026680:C:T | C159Y | 0.766 |
| 17:41026695:C:G | C154S | 0.766 |
| 17:41026696:A:T | C154S | 0.766 |
| 17:41026745:G:C | S137R | 0.761 |
| 17:41026745:G:T | S137R | 0.761 |
| 17:41026747:T:G | S137R | 0.761 |
| 17:41026664:G:C | C164W | 0.760 |
| 17:41026666:A:G | C164R | 0.747 |
| 17:41026652:G:C | C168W | 0.741 |
| 17:41026654:A:G | C168R | 0.741 |
| 17:41026649:G:C | C169W | 0.733 |
| 17:41027024:G:C | F44L | 0.730 |
| 17:41027024:G:T | F44L | 0.730 |
dbSNP variants (sampled 300 via entrez): RS1000752837 (17:41028407 C>T), RS1002311197 (17:41028265 A>G), RS1002477294 (17:41027921 G>A), RS1003221303 (17:41026836 C>A,T), RS1004211538 (17:41027897 G>A), RS1004542832 (17:41029205 G>A), RS1004709342 (17:41027583 T>G), RS1006992553 (17:41027766 C>T), RS1007698002 (17:41028832 A>G), RS1008359665 (17:41027509 G>A,T), RS1008819530 (17:41028612 C>T), RS1008913396 (17:41027244 G>C,T), RS1009140730 (17:41028813 G>A), RS1009407457 (17:41028755 G>T), RS1009808533 (17:41028451 A>G)
Disease associations
OMIM: gene MIM:608822 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 1 |
| diallyl trisulfide | increases expression | 1 |
| pentanal | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Mercuric Chloride | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
| Particulate Matter | increases abundance, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.